Fortrea holdings inc FTRE.US 總覽分析
)FTRE 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
FTRE 近期報酬表現
2.96%
Fortrea holdings inc
3.56%
同產業平均
1.47%
S&P500
與 FTRE 同產業的標的表現
- CRL Charles river laboratories international inc價值 4 分趨勢 1 分波段 4 分籌碼 3 分股利 1 分查看更多
FTRE 公司資訊
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.